Reliant Medical Group, Worcester, Massachusetts, USA.
UMass Medical School, Worcester, Massachusetts, USA.
Influenza Other Respir Viruses. 2022 Nov;16(6):1141-1150. doi: 10.1111/irv.13041. Epub 2022 Sep 13.
The objective of this study was to test a novel household-based approach to improve late-season influenza vaccine uptake during the 2020-2021 season, using Epic's MyChart patient portal messages and/or interactive voice response telephone calls.
This study was a non-blinded, quality improvement program using a block randomized design conducted among patients from Reliant Medical Group clinics residing in a traditional household (≥2 individuals clinically active in the Reliant system living at the same address). Households were randomized 1:1:1 into intervention arms: non-tailored communication (messaging based on CDC's seasonal influenza vaccination campaign), tailored communication (comprehensive communication including reinforcement of the importance of influenza vaccination for high-risk individuals), and standard-of-care control. Influenza vaccination during the program was captured via medical records, and the odds of vaccination among communication arms versus the control arm were assessed. A survey assessing influenza vaccination drivers was administered using MyChart.
Influenza vaccination increased by 3.3% during the program period, and no significant differences in vaccination were observed in intervention arms relative to the control arm. Study operationalization faced substantial challenges related to the concurrent COVID-19 pandemic. Compared with vaccinated survey respondents, unvaccinated respondents less frequently reported receiving a recommendation for influenza vaccination from their healthcare provider (15.8% vs. 42.3%, p < 0.001) or awareness that vaccination could protect themselves and higher risk contacts (82.3% vs. 92.6%, p < 0.001).
No significant effects of the interventions were observed. Survey results highlighted the importance of healthcare provider recommendations and the need for increased education around the benefits of vaccination.
本研究旨在测试一种新颖的家庭为基础的方法,以提高 2020-2021 季节的后期流感疫苗接种率,使用 Epic 的 MyChart 患者门户信息和/或交互式语音应答电话。
本研究为非盲、质量改进项目,采用传统家庭(≥2 名在 Reliant 系统中临床活跃的个体居住在同一地址)的患者进行了块随机设计。家庭随机分为 1:1:1 干预组:非定制沟通(基于疾病预防控制中心季节性流感疫苗接种活动的信息)、定制沟通(包括强化高危个体流感疫苗接种重要性的全面沟通)和标准护理对照组。通过病历记录捕获流感疫苗接种情况,并评估沟通组与对照组之间的疫苗接种几率。使用 MyChart 进行了一项评估流感疫苗接种驱动因素的调查。
在项目期间,流感疫苗接种率增加了 3.3%,但干预组与对照组相比,疫苗接种率没有显著差异。研究实施面临着与 COVID-19 大流行同时发生的巨大挑战。与接种调查受访者相比,未接种受访者较少报告从医疗保健提供者那里获得流感疫苗接种建议(15.8%比 42.3%,p<0.001)或意识到疫苗接种可以保护自己和高风险接触者(82.3%比 92.6%,p<0.001)。
未观察到干预措施的显著效果。调查结果强调了医疗保健提供者建议的重要性,以及需要增加疫苗接种益处的教育。